March 9-12, 2020
Santa Clara Convention Center,
Santa Clara, California, USA
THE LEADING PHASE-BASED BIOPROCESSING EVENT FOR ADVANCING PROMISING BIOLOGICS TOWARDS COMMERCIAL SUCCESS
Thank you to all who attended our BPI US West 2018 meeting!
Mark your calendar for next year's meeting, held March 9-12, 2020 as we return to the Santa Clara Convention Center
Hear from the brightest minds in bioprocessing
The BPI US West 2019 speakers consisted of top scientists and engineers working across the entire bioprocessing spectrum.
improve the speed, lower the cost and increase the quality/safety of biologics development
Ensure regulatory success
New for 2019, our viral safety track keeps you up-to-date on how today's industry leaders are implementing successful virus detection and viral removal programs.
Advance promising biologics to IND
Our early stage process development track covers global best practices to reduce timelines, lower costs, develop robust cell lines, and utilize new technologies in downstream processing.
Increase product speed to market
The late stage process development track shares best practices for developing continuous and intensified processes, achieving process robustness and simplification, streamlining process validation and characterization, and alleviating bottlenecks in tech transfers and scale up.
Create a sustainable commercial manufacturing program
Our commercial manufacturing track provides innovating strategies for capacity and continuous improvements, successful launch and lifecycle management, optimizing operational efficiencies, and achieving real-time control strategies.
Accelerate development for multi-product pipelines, global markets and capacity optimization
Attend our single-use/flexible facilities track to learn how both large and small pharma are meeting today's requirements for validation, supply chain, design and operational considerations.
GAIN THE SCIENCE, TECHNOLOGIES AND CONTACTS YOU NEED TO ACCELERATE BIOLOGICS TO MARKET
THE LEADING SCIENCE
The scientific agenda offers 100+ speaker presentations designed to improve the speed, cost and quality of your process development and manufacturing efforts.
Our large, multi-track format presents innovative scientific developments, industry updates and technology applications across the entire bioprocessing spectrum from early stage process development through commercial launch preparation.
THE MOST INNOVATIVE TECHNOLOGY
The exhibit hall gathers 80+ exhibitors representing global CMOs, CROs, suppliers and technology leaders who can help your company accelerate your product to market.
See live product demonstrations and discuss your needs with knowledgeable vendors from all over the world.
THE RIGHT PARTNERS FOR YOU
Whether you are looking to meet potential customers or partners, BPI West is the one-stop shop to network with global scientists and decision makers working across all aspects of the biopharmaceutical field.
Attendee luncheons, poster viewing hours and evening cocktail receptions offer simple yet effective networking opportunities. Plus, your registration includes access to the BPI West app, allowing you to view the entire attendee list and schedule meetings before, during and after the event.
"This conference brings together leading researchers in biopharma along the entire lifecycle of products. It is an important venue for sharing of key information and moving the field forward."
Gargi Haheshwari, Ph.D.
Executive Director, Biologics Process Development & Commercialization,
Merck
"Sharing experiences helps us as individuals, but also projects, companies and the industry, ultimately leading to better drugs for patients."
Mark R.H. Krebs, Ph.D.
Senior Scientist, Technical Development
Biogen
"BPI West is an ideal meeting to share experiences with industry leaders in the bioprocess field."
William N. Napoli
Scientist, BioProcess Technology and Expression, BioProcess Development
Merck & Co., Inc.
Thank you to our Advisors
With the help of our outstanding advisory board below, the BPI US West agenda includes many of the brightest minds in bioprocessing to keep you up-to-date on industry trends and challenges across the entire bioprocessing spectrum.
David Brindley, Ph.D., Senior Research Fellow, University of Oxford
David Brühlmann, Ph.D., Manager, Biotech Process, Merck
Hanmin Dong, Senior Scientist I, Abbvie Biotherapeutics Inc.
Sabine Gaillard, Ph.D., Scientist, Bioprocess Research & Development, Sanofi Pasteur
Jente Lu, Ph.D., Senior Scientist I, BioMarin Pharmaceuticals
Jeffrey Guss, Automation/Informatics Engineer, GSK
Padmadhar Madupu, Manager Process Engineering & Development, Pfizer
Shawn Liu PhD, Chief Scientist & Department Head, Bayer
Sourav Kundu Ph.D., Sr Director, Process Development, TEVA
Yuyi Shen Ph.D., Senior Process Expert, Grifols
Arnie Horowitz Ph.D., retired from Xoma, Consultant
Ashley Hesslein, Ph.D., Associate Director, Bayer
Ali Ghoorchian, Ph.D., Senior Scientist II, Manufacturing Science and Technology, Pfizer
Sigma Mostafa, Ph.D., Vice President, Process Development, KBI Biopharma, Inc.
Nobel Vale, Research Scientist, Analytical & BioanalyticalDevelopment, Bristol-Myers Squibb
Kyle Zingaro, Ph.D., Development Scientist II, Early Stage Process Development, Alexion Pharmaceuticals, Inc.